Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies
暂无分享,去创建一个
D. Girelli | L. Cariani | C. Colombo | F. Ferraro | V. Daccó | G. Alicandro | C. Rosazza | P. Medino | C. Lanfranchi | C. Sciarrabba | V. Daccò